1.65

4.43% 0.07

After Hours: 1.61 -0.04 -2.42%

Protagenic Therapeutics Inc (PTIX)

Overview News Price History Financials Discussions Forecast Stock Split

Protagenic Therapeutics Inc stock is traded at $1.65, with a volume of 112.85K. It is up +4.43% in the last 24 hours and down -14.06% over the past month. Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Previous Close:

$1.58

Open:

$1.56

24h Volume:

112.85K

Relative Volume:

1.19

Market Cap:

$3.18M

Revenue:

Net Income/Loss:

$-5.00M

P/E Ratio:

-1.4348

EPS:

-1.15

Net Cash Flow:

$-3.85M

1W Performance:

-1.20%

1M Performance:

-14.06%

6M Performance:

-53.12%

1Y Performance:

-77.12%

1-Day Range:

$1.55

$1.6762

1-Week Range:

$1.46

$1.77

52-Week Range:

$1.46

$14.28

Protagenic Therapeutics Inc Stock (PTIX) Company Profile

Name

Protagenic Therapeutics Inc

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

(212) 994-8200

Address

149 FIFTH AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

PTIX's Discussions on Twitter

Compare PTIX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PTIX Protagenic Therapeutics Inc	1.65	3.05M	0	-5.00M	-3.85M	-1.15
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Protagenic Therapeutics Inc Stock (PTIX) Latest News

Dec 13, 2025

What analysts say about Protagenic Therapeutics Inc stockValue Stock Picks & Rapid Capital Gain - earlytimes.in

Dec 13, 2025

Dec 11, 2025

Protagenic reports results from phase 1 multiple-dose study of PT00114 - MSN

Dec 11, 2025

Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice - Bluffton Today

Dec 11, 2025

Dec 10, 2025

Taking on analysts’ expectations and winning: Protagenic Therapeutics Inc (PTIX) - setenews.com

Dec 10, 2025

Dec 09, 2025

Protagenic Therapeutics (PTIX) Shares Phase 1 Study Results for PT00114 - GuruFocus

Dec 09, 2025

Protagenic reports positive safety results for stress disorder drug - Investing.com

Dec 09, 2025

Protagenic reports positive safety results for stress disorder drug By Investing.com - Investing.com Australia

Dec 09, 2025

Results from Phase 1 Multiple-Dose Study of PT00114 - ACCESS Newswire

Dec 09, 2025

Dec 05, 2025

Will Protagenic Therapeutics Inc. (MBP0) stock profit from automation waveWeekly Trade Recap & Pattern Based Trade Signal System - Newser

Dec 05, 2025

Is Protagenic Therapeutics Inc. (MBP0) stock a buy before new product rollout2025 Support & Resistance & Daily Profit Focused Stock Screening - Newser

Dec 05, 2025

Will Protagenic Therapeutics Inc. (MBP0) stock enhance shareholder valueJuly 2025 Fed Impact & Scalable Portfolio Growth Methods - Newser

Dec 05, 2025

Can Protagenic Therapeutics Inc. (MBP0) stock expand revenue streamsJuly 2025 Snapshot & Free Real-Time Market Sentiment Alerts - Newser

Dec 05, 2025

How dovish Fed policy supports Protagenic Therapeutics Inc. (MBP0) stockQuarterly Market Review & Free High Return Stock Watch Alerts - Newser

Dec 05, 2025

Is Protagenic Therapeutics Inc. Equity Warrant stock positioned well for digital economy2025 Market Sentiment & Risk Adjusted Buy and Sell Alerts - Newser

Dec 05, 2025

Dec 04, 2025

Is Protagenic Therapeutics Inc. stock gaining market shareJuly 2025 Weekly Recap & Community Supported Trade Ideas - Newser

Dec 04, 2025

Can Protagenic Therapeutics Inc. (MBP0) stock attract ESG investmentsJuly 2025 Rallies & Technical Pattern Alert System - Newser

Dec 04, 2025

Dec 03, 2025

CapEx per share of Protagenic Therapeutics, Inc. – GETTEX:MBP0 - TradingView

Dec 03, 2025

Will Protagenic Therapeutics Inc. Equity Warrant stock attract ESG investorsMarket Sentiment Review & Daily Momentum Trading Reports - Newser

Dec 03, 2025

How Protagenic Therapeutics Inc. (MBP0) stock behaves in tightening cycles2025 Winners & Losers & Low Risk Investment Opportunities - Newser

Dec 03, 2025

Why Protagenic Therapeutics Inc. (MBP0) stock could be next leaderJuly 2025 Sentiment & Stepwise Trade Execution Plans - Newser

Dec 03, 2025

Dec 02, 2025

Protagenic Therapeutics (PTIX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

How robust is Protagenic Therapeutics Inc. (MBP0) stock financial position - Newser

Dec 02, 2025

Why Protagenic Therapeutics Inc. (MBP0) stock is a must watch tickerMarket Growth Review & Free Technical Pattern Based Buy Signals - Newser

Dec 02, 2025

Dec 01, 2025

ETF Watch: Can Protagenic Therapeutics Inc stock maintain growth trajectoryGlobal Markets & Entry Point Strategy Guides - BỘ NỘI VỤ

Dec 01, 2025

Nov 29, 2025

US Stocks Recap: Can Protagenic Therapeutics Inc. stock maintain growth trajectoryGDP Growth & Proven Capital Preservation Tips - BỘ NỘI VỤ

Nov 29, 2025

Nov 28, 2025

Protagenic Therapeutics Faces Nasdaq Delisting Due to Compliance Issues - marketscreener.com

Nov 28, 2025

Nov 27, 2025

Can Protagenic Therapeutics Inc. stock maintain growth trajectoryEarnings Overview Report & Free Expert Approved Momentum Trade Ideas - moha.gov.vn

Nov 27, 2025